Lead party: ASP Isotopes Inc. (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Molybdos (Pty) Limited (private company) · Sector: Healthcare, Biotechnology, Pharmaceuticals · Countries of operation: South Africa
Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Carve-Out · Instrument: Equity · Deal amount: US$726,744 · Equity stake: 1% · Implied EV: US$726,744
Lead investor/buyer: ASP Isotopes Inc. · Investors/buyers: ASP Isotopes Inc.
Legal advisers: not identified in the source record.
Source: announced 30 September 2021. Original announcement: ir.aspisotopes.com.


